131 related articles for article (PubMed ID: 3252078)
1. In-vitro susceptibility to aztreonam.
Lim VK
Malays J Pathol; 1988 Aug; 10():61-4. PubMed ID: 3252078
[No Abstract] [Full Text] [Related]
2. Aztreonam.
Outman WR
Conn Med; 1987 Sep; 51(9):611-3. PubMed ID: 3311617
[No Abstract] [Full Text] [Related]
3. Aztreonam: a narrow spectrum against gram-negative aerobes.
Drug Ther Bull; 1987 Nov; 25(22):86-8. PubMed ID: 3315541
[No Abstract] [Full Text] [Related]
4. [Evaluation of the clinical effectiveness of aztreonam in gram-negative infections of the biliary tract].
Pedretti G; Magnani G
G Ital Chemioter; 1988; 35(1-3):45-8. PubMed ID: 3256512
[No Abstract] [Full Text] [Related]
5. [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli].
Peter JD; Jehl F; Froehly S; Dupeyron JP; Monteil H; Rosset MA
Pathol Biol (Paris); 1988 May; 36(5):525-30. PubMed ID: 3043352
[TBL] [Abstract][Full Text] [Related]
6. [Aztreonam. A small-spectrum antibiotic in gram-negative infections].
Sander J
Tidsskr Nor Laegeforen; 1991 Aug; 111(18):2277-8. PubMed ID: 1896987
[No Abstract] [Full Text] [Related]
7. Aztreonam in the therapy of severe gram-negative infections.
Davies A; Stone J; Hassan A; Quarty P; Green T
Chemioterapia; 1987 Jun; 6(2 Suppl):389-90. PubMed ID: 3509455
[No Abstract] [Full Text] [Related]
8. Aminoglycosides, imipenem, and aztreonam.
Johnson JG; Hardin TC
Clin Podiatr Med Surg; 1992 Apr; 9(2):443-64. PubMed ID: 1586911
[TBL] [Abstract][Full Text] [Related]
9. Aztreonam: an appraisal.
Neu HC
N J Med; 1986 Jan; Spec No():42-5. PubMed ID: 3485269
[No Abstract] [Full Text] [Related]
10. [Criteria for the selection of antibiotics in the empirical therapy of gram negative infections].
Betts RF
Internist (Berl); 1981 Nov; 22(11):710-4. PubMed ID: 7031008
[No Abstract] [Full Text] [Related]
11. [Incidence and antibiotic-sensitivity of gram-negative bacteria in the urinary infections (author's transl)].
Lechi A; Arosio E; Pancera P; Montesi G; Mengoli C; Biscardo G; Bonomi U
Quad Sclavo Diagn; 1980 Sep; 16(3):282-7. PubMed ID: 7244101
[TBL] [Abstract][Full Text] [Related]
12. [Aztreonam in infections caused by gram-negative aerobic bacilli].
Rodríguez French A; Kenion G; Rodríguez C
Rev Med Panama; 1988 Jan; 13(1):4-8. PubMed ID: 3347772
[No Abstract] [Full Text] [Related]
13. [Effect of aztreonam on the fecal aerobic flora in children].
Borderon JC; Rastegar A; Ramponi N; Gold F; Laugier J
Pathol Biol (Paris); 1987 May; 35(5):665-8. PubMed ID: 3112714
[TBL] [Abstract][Full Text] [Related]
14. Aztreonam: correlation between disk diffusion and agar plate dilutions susceptibility tests.
Toma EC; Morisset R; Phaneuf D; Poisson M
Chemotherapy; 1985; 31(6):451-5. PubMed ID: 4075858
[TBL] [Abstract][Full Text] [Related]
15. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
Malcangi A; Pesce S; Vitale M; Martinetto P
G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
[TBL] [Abstract][Full Text] [Related]
16. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
Honderlick P; Gravisse J; Dardelle D; Cahen P
Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the therapeutic efficacy of aztreonam in the treatment of infection caused by sensitive microorganisms].
Tirone F; Musca G; Filomia D; Vigna L
Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):85-8. PubMed ID: 2798996
[TBL] [Abstract][Full Text] [Related]
18. Aztreonam: early clinical studies in New Jersey.
Johnson ES; Eng RK; Perez EM; Smith LG
N J Med; 1986 Jan; Spec No():26-9. PubMed ID: 3513061
[No Abstract] [Full Text] [Related]
19. [Role of the new beta lactams in severe infections. Imipenem and aztreonam: indications and limitations].
Sánchez C; Garau J
Enferm Infecc Microbiol Clin; 1989; 7 Suppl 1():67-75. PubMed ID: 2490491
[No Abstract] [Full Text] [Related]
20. [Significance of non-fermentative gram-negative bacteria in infections. Bacteriological and clinical aspects].
Turcu T; Liscă M
Rev Med Chir Soc Med Nat Iasi; 1981; 85(2):275-82. PubMed ID: 7051218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
